ProPhase Labs, Inc.
PRPH
$0.11
-$0.02-16.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -29.19% | -12.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -29.19% | -12.86% | |||
| Cost of Revenue | 96.10% | -43.31% | |||
| Gross Profit | -116.76% | 39.54% | |||
| SG&A Expenses | 0.24% | 13.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.84% | 0.92% | |||
| Operating Income | -22.34% | -6.31% | |||
| Income Before Tax | -89.44% | 21.06% | |||
| Income Tax Expenses | -120.15% | -- | |||
| Earnings from Continuing Operations | -52.93% | 4.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.93% | -212.76% | |||
| EBIT | -22.34% | -6.31% | |||
| EBITDA | -46.40% | -16.69% | |||
| EPS Basic | -52.83% | -195.65% | |||
| Normalized Basic EPS | -179.18% | 48.34% | |||
| EPS Diluted | -49.64% | -197.69% | |||
| Normalized Diluted EPS | -179.18% | 48.34% | |||
| Average Basic Shares Outstanding | 0.00% | 17.90% | |||
| Average Diluted Shares Outstanding | 0.00% | 17.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||